Lexeo Therapeutics, Inc. Common Stock
Lexeo Therapeutics, Inc. Common Stock (LXEO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LXEO · as of Jun 8, 2026
Key Statistics
Explore Lexeo Therapeutics, Inc. Common Stock Data
lxeo stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 100.0%
The LXEO analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $18.33, representing +328.27% upside from the current price of $4.28.
Competitors & Peers
lxeo competitorsLXEO
AMRN
CAPR
CTNM
DBVT
KYTXStock Performance
Full HistoryAbout Lexeo Therapeutics, Inc. Common Stock
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy can…
what is lexeo therapeutics, inc. common stock · lxeo stock overview · lexeo therapeutics, inc. common stock company profile · who is lexeo therapeutics, inc. common stock ceo · lxeo NASDAQ · lexeo therapeutics, inc. common stock headquarters · lexeo therapeutics, inc. common stock business segments
About Stock Overview & Key Data
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 3, 2023. As of the latest trading session, LXEO stock price is $4.28, with a market capitalization of $329.8M. The stock has returned -4.11% over the past 12 months and -57.70% year-to-date.
According to 5 Wall Street analysts, the consensus rating for Lexeo Therapeutics, Inc. Common Stock stock is Buy, with an average 12-month price target of $18.33. In fiscal year 2025, Lexeo Therapeutics, Inc. Common Stock reported revenue of — and net income of -$100.0M. For detailed data — including Lexeo Therapeutics, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Lexeo Therapeutics, Inc. Common Stock (LXEO) stock price is $4.28. The stock is traded on NASDAQ under the ticker symbol LXEO. The 52-week range is $2.90 – $10.99.